Biotechnology
The Biotechnology industry has a total of 589 stocks, with a combined market cap of $1.12 trillion and total revenue of $109.89 billion.
Market Cap
1.12T
Revenue
109.89B
Profits
-41.34B
PE Ratio
n/a
Profit Margin
-37.62%
Dividend Yield
0.04%
589 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 115.02B | 0.60% | 1,486,576 | 12.22B |
| 2 | REGN | Regeneron Pharmaceuticals, Inc. | 62.54B | -0.04% | 1,007,464 | 14.92B |
| 3 | ARGX | argenx SE | 54.54B | -0.65% | 314,815 | 4.74B |
| 4 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.64B | -2.05% | 1,213,289 | 4.29B |
| 5 | RVMD | Revolution Medicines, Inc. | 33.29B | -2.17% | 2,523,690 | - |
| 6 | RPRX | Royalty Pharma plc | 31.22B | -0.11% | 2,841,826 | 2.44B |
| 7 | ONC | BeOne Medicines AG | 29.34B | -1.60% | 299,595 | 5.70B |
| 8 | BNTX | BioNTech SE | 22.63B | -1.43% | 819,247 | 3.23B |
| 9 | MRNA | Moderna, Inc. | 21.98B | 6.27% | 13,050,524 | 2.23B |
| 10 | ROIV | Roivant Sciences Ltd. | 21.87B | 1.27% | 3,886,429 | 8.26M |
| 11 | INSM | Insmed Incorporated | 20.70B | -1.99% | 3,423,653 | 819.56M |
| 12 | INCY | Incyte Corporation | 19.93B | -2.19% | 1,556,318 | 5.36B |
| 13 | GMAB | Genmab A/S | 14.83B | 0.65% | 2,191,662 | 3.90B |
| 14 | ASND | Ascendis Pharma A/S | 14.36B | 3.54% | 812,462 | 998.25M |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 14.24B | -1.61% | 770,225 | 4.44B |
| 16 | EXEL | Exelixis, Inc. | 13.10B | -1.70% | 1,676,460 | 2.38B |
| 17 | BBIO | BridgeBio Pharma, Inc. | 13.05B | -2.00% | 2,738,202 | 579.96M |
| 18 | AXSM | Axsome Therapeutics, Inc. | 12.96B | -0.59% | 684,263 | 708.24M |
| 19 | IONS | Ionis Pharmaceuticals, Inc. | 12.08B | -1.18% | 1,801,390 | 1.06B |
| 20 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.56B | 0.29% | 319,891 | 1.13B |
| 21 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.78B | -0.78% | 917,092 | 622.01M |
| 22 | SMMT | Summit Therapeutics Inc. | 10.77B | -1.77% | 5,505,390 | - |
| 23 | BMRN | BioMarin Pharmaceutical Inc. | 10.65B | -0.95% | 1,524,422 | 3.24B |
| 24 | CYTK | Cytokinetics, Incorporated | 10.21B | 5.37% | 3,973,986 | 105.82M |
| 25 | NUVL | Nuvalent, Inc. | 9.75B | 0.03% | 2,257,552 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 9.53B | -0.42% | 328,905 | 417.30M |
| 27 | CORT | Corcept Therapeutics Incorporated | 8.99B | 0.71% | 767,927 | 769.10M |
| 28 | TECH | Bio-Techne Corporation | 8.77B | -0.25% | 1,529,618 | 1.21B |
| 29 | HALO | Halozyme Therapeutics, Inc. | 8.26B | -2.30% | 1,950,032 | 1.51B |
| 30 | ABVX | ABIVAX Société Anonyme | 7.73B | -0.77% | 1,944,989 | 5.67M |
| 31 | SYRE | Spyre Therapeutics, Inc. | 7.24B | -0.20% | 1,337,113 | - |
| 32 | KYMR | Kymera Therapeutics, Inc. | 7.19B | 2.16% | 588,187 | 51.48M |
| 33 | PRAX | Praxis Precision Medicines, Inc. | 7.17B | -2.76% | 502,166 | 7.46M |
| 34 | TGTX | TG Therapeutics, Inc. | 7.16B | 0.48% | 1,993,274 | 700.35M |
| 35 | PCVX | Vaxcyte, Inc. | 7.12B | -0.50% | 1,003,789 | - |
| 36 | PTGX | Protagonist Therapeutics, Inc. | 7.12B | -1.62% | 504,795 | 74.06M |
| 37 | IBRX | ImmunityBio, Inc. | 7.04B | -5.75% | 12,797,590 | 140.98M |
| 38 | IMVT | Immunovant, Inc. | 6.90B | 0.51% | 1,165,780 | - |
| 39 | APGE | Apogee Therapeutics, Inc. | 6.39B | -1.10% | 1,045,104 | - |
| 40 | LEGN | Legend Biotech Corporation | 6.20B | -5.92% | 2,005,485 | 1.14B |
| 41 | MIRM | Mirum Pharmaceuticals, Inc. | 6.19B | 0.54% | 868,733 | 569.61M |
| 42 | CNTA | Centessa Pharmaceuticals plc | 6.15B | -0.03% | 2,216,243 | 15.00M |
| 43 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.15B | 0.02% | 609,838 | 217.17M |
| 44 | PTCT | PTC Therapeutics, Inc. | 6.08B | -4.56% | 6,044,173 | 827.11M |
| 45 | COGT | Cogent Biosciences, Inc. | 5.65B | -0.30% | 1,603,105 | - |
| 46 | SRRK | Scholar Rock Holding Corporation | 5.46B | -0.78% | 957,643 | - |
| 47 | BLTE | Belite Bio, Inc | 5.44B | -4.19% | 300,258 | - |
| 48 | CGON | CG Oncology, Inc. | 5.32B | 1.23% | 530,820 | 5.07M |
| 49 | LGND | Ligand Pharmaceuticals Incorporated | 5.12B | 0.79% | 220,585 | 274.48M |
| 50 | CAI | Caris Life Sciences, Inc. | 5.08B | -1.10% | 1,804,635 | 907.29M |
| 51 | XENE | Xenon Pharmaceuticals Inc. | 5.03B | -0.78% | 709,999 | 7.50M |
| 52 | CRSP | CRISPR Therapeutics AG | 5.02B | -1.12% | 1,103,359 | 4.10M |
| 53 | TVTX | Travere Therapeutics, Inc. | 4.96B | -0.78% | 2,130,792 | 536.20M |
| 54 | TNGX | Tango Therapeutics, Inc. | 4.65B | -2.25% | 3,096,389 | 56.99M |
| 55 | DNTH | Dianthus Therapeutics, Inc. | 4.31B | -4.40% | 910,527 | 1.34M |
| 56 | CELC | Celcuity Inc. | 4.26B | -1.04% | 906,055 | - |
| 57 | ERAS | Erasca, Inc. | 4.16B | -7.28% | 3,929,251 | - |
| 58 | ORKA | Oruka Therapeutics, Inc. | 4.08B | -1.67% | 816,217 | - |
| 59 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.84B | -0.06% | 1,837,525 | 596.96M |
| 60 | MANE | Veradermics, Incorporated | 3.80B | -5.53% | 513,731 | - |
| 61 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | -0.34% | 694,866 | 18.07M |
| 62 | EWTX | Edgewise Therapeutics, Inc. | 3.65B | -3.58% | 6,423,447 | - |
| 63 | ACAD | ACADIA Pharmaceuticals Inc. | 3.59B | -1.55% | 1,242,241 | 1.10B |
| 64 | NAMS | NewAmsterdam Pharma Company N.V. | 3.53B | -1.34% | 1,156,636 | 22.57M |
| 65 | DNLI | Denali Therapeutics Inc. | 3.48B | -1.31% | 1,455,916 | - |
| 66 | VKTX | Viking Therapeutics, Inc. | 3.44B | 0.07% | 1,375,723 | - |
| 67 | PBLS | Parabilis Medicines, Inc. | 3.39B | 6.32% | 3,384,251 | - |
| 68 | TLX | Telix Pharmaceuticals Limited | 3.32B | 0.42% | 555,739 | 803.79M |
| 69 | RLAY | Relay Therapeutics, Inc. | 3.28B | 0.60% | 2,338,445 | 10.68M |
| 70 | ARQT | Arcutis Biotherapeutics, Inc. | 3.21B | 0.35% | 1,537,145 | 415.62M |
| 71 | BEAM | Beam Therapeutics Inc. | 3.08B | -0.42% | 1,205,261 | 164.01M |
| 72 | GPCR | Structure Therapeutics Inc. | 3.05B | -0.37% | 714,936 | - |
| 73 | DYN | Dyne Therapeutics, Inc. | 2.99B | -3.52% | 1,137,497 | - |
| 74 | RCUS | Arcus Biosciences, Inc. | 2.96B | -2.61% | 694,995 | 236.00M |
| 75 | ALMS | Alumis Inc. | 2.85B | -2.96% | 888,819 | 8.40M |
| 76 | IDYA | IDEAYA Biosciences, Inc. | 2.69B | 1.12% | 1,168,602 | 225.27M |
| 77 | IRON | Disc Medicine, Inc. | 2.67B | -0.37% | 339,443 | - |
| 78 | DFTX | Definium Therapeutics, Inc. | 2.64B | 1.64% | 1,200,622 | - |
| 79 | TARS | Tarsus Pharmaceuticals, Inc. | 2.62B | -1.70% | 718,793 | 535.08M |
| 80 | ELVN | Enliven Therapeutics, Inc. | 2.59B | 0.45% | 3,453,868 | - |
| 81 | CLDX | Celldex Therapeutics, Inc. | 2.54B | 0.62% | 999,435 | 865.00K |
| 82 | RARE | Ultragenyx Pharmaceutical Inc. | 2.44B | -2.09% | 2,747,383 | 670.00M |
| 83 | VERA | Vera Therapeutics, Inc. | 2.42B | -1.66% | 1,533,381 | - |
| 84 | KLRA | Kailera Therapeutics, Inc. | 2.40B | -5.69% | 723,293 | - |
| 85 | PHVS | Pharvaris N.V. | 2.20B | -0.25% | 149,285 | - |
| 86 | TRVI | Trevi Therapeutics, Inc. | 2.19B | 5.05% | 3,430,158 | - |
| 87 | AUPH | Aurinia Pharmaceuticals Inc. | 2.09B | 1.37% | 1,372,430 | 298.30M |
| 88 | KOD | Kodiak Sciences Inc. | 2.06B | -3.29% | 412,886 | - |
| 89 | NKTR | Nektar Therapeutics | 2.04B | -1.44% | 725,569 | 55.63M |
| 90 | NTLA | Intellia Therapeutics, Inc. | 2.03B | -2.48% | 8,657,707 | 66.09M |
| 91 | IMNM | Immunome, Inc. | 2.03B | -0.89% | 877,500 | 4.02M |
| 92 | ZLAB | Zai Lab Limited | 1.99B | - | 354,982 | 453.28M |
| 93 | ADMA | ADMA Biologics, Inc. | 1.99B | 0.94% | 3,402,361 | 509.86M |
| 94 | MLYS | Mineralys Therapeutics, Inc. | 1.98B | 0.29% | 1,434,643 | - |
| 95 | VCEL | Vericel Corporation | 1.96B | 0.44% | 644,396 | 292.09M |
| 96 | HRMY | Harmony Biosciences Holdings, Inc. | 1.96B | -1.02% | 477,334 | 899.11M |
| 97 | OCUL | Ocular Therapeutix, Inc. | 1.96B | -0.56% | 2,329,712 | 52.04M |
| 98 | MBX | MBX Biosciences, Inc. | 1.91B | 2.85% | 1,144,949 | - |
| 99 | AGIO | Agios Pharmaceuticals, Inc. | 1.89B | 0.06% | 788,088 | 66.05M |
| 100 | LKFT | Lakefront Biotherapeutics NV | 1.84B | -1.67% | 199,975 | 1.20B |
| 101 | RAPP | Rapport Therapeutics, Inc. | 1.84B | 0.60% | 157,087 | 20.00M |
| 102 | BHVN | Biohaven Ltd. | 1.82B | -0.41% | 2,375,051 | - |
| 103 | STOK | Stoke Therapeutics, Inc. | 1.82B | -2.83% | 410,747 | 32.08M |
| 104 | MESO | Mesoblast Limited | 1.81B | -0.07% | 124,881 | 65.38M |
| 105 | NBTX | Nanobiotix S.A. | 1.78B | -3.04% | 64,357 | 38.27M |
| 106 | NUVB | Nuvation Bio Inc. | 1.78B | -0.39% | 3,625,161 | 143.05M |
| 107 | NRIX | Nurix Therapeutics, Inc. | 1.77B | 0.18% | 2,675,713 | 71.78M |
| 108 | VRDN | Viridian Therapeutics, Inc. | 1.76B | -1.96% | 1,260,585 | 70.92M |
| 109 | GENB | Generate Biomedicines, Inc. | 1.71B | -1.55% | 631,872 | 30.30M |
| 110 | IOVA | Iovance Biotherapeutics, Inc. | 1.71B | -5.21% | 9,003,992 | 285.61M |
| 111 | QURE | uniQure N.V. | 1.70B | -3.16% | 613,502 | 18.09M |
| 112 | PGEN | Precigen, Inc. | 1.69B | -1.04% | 3,576,790 | 31.60M |
| 113 | RXRX | Recursion Pharmaceuticals, Inc. | 1.69B | -3.34% | 15,477,041 | 66.41M |
| 114 | TSHA | Taysha Gene Therapies, Inc. | 1.68B | -2.01% | 1,653,824 | 7.47M |
| 115 | TYRA | Tyra Biosciences, Inc. | 1.68B | -1.19% | 633,596 | - |
| 116 | ANAB | AnaptysBio, Inc. | 1.68B | -3.19% | 402,955 | 232.39M |
| 117 | INVA | Innoviva, Inc. | 1.67B | 0.85% | 564,707 | 420.69M |
| 118 | SRPT | Sarepta Therapeutics, Inc. | 1.67B | 0.06% | 2,195,676 | 2.18B |
| 119 | SNDX | Syndax Pharmaceuticals, Inc. | 1.64B | 0.38% | 2,166,919 | 217.17M |
| 120 | ZYME | Zymeworks Inc. | 1.64B | -3.31% | 596,829 | 81.26M |
| 121 | SEPN | Septerna, Inc. | 1.59B | -2.39% | 284,028 | 72.26M |
| 122 | PVLA | Palvella Therapeutics, Inc. | 1.58B | -5.48% | 251,736 | - |
| 123 | SION | Sionna Therapeutics, Inc. | 1.57B | -3.47% | 375,116 | - |
| 124 | URGN | UroGen Pharma Ltd. | 1.56B | 3.50% | 571,955 | 140.49M |
| 125 | ABCL | AbCellera Biologics Inc. | 1.55B | -3.23% | 3,648,493 | 79.21M |
| 126 | AAPG | Ascentage Pharma Group International | 1.55B | -1.90% | 13,974 | 82.08M |
| 127 | ATAI | AtaiBeckley Inc. | 1.52B | 7.81% | 10,009,481 | 3.49M |
| 128 | NVAX | Novavax, Inc. | 1.51B | -0.11% | 4,168,435 | 596.34M |
| 129 | FTRE | Fortrea Holdings Inc. | 1.51B | -3.91% | 1,472,727 | 2.71B |
| 130 | CAPR | Capricor Therapeutics, Inc. | 1.51B | -2.51% | 654,951 | 11.13M |
| 131 | GLUE | Monte Rosa Therapeutics, Inc. | 1.50B | -1.99% | 795,061 | 42.95M |
| 132 | VIR | Vir Biotechnology, Inc. | 1.45B | - | 1,377,850 | 65.50M |
| 133 | BCAX | Bicara Therapeutics Inc. | 1.44B | 1.81% | 386,254 | - |
| 134 | SLBT | SL Science Holding Limited | 1.44B | 166.97% | 33,166,925 | - |
| 135 | IMCR | Immunocore Holdings plc | 1.43B | -1.61% | 254,359 | 412.81M |
| 136 | AVBP | ArriVent BioPharma, Inc. | 1.41B | 0.10% | 429,941 | - |
| 137 | SLS | SELLAS Life Sciences Group, Inc. | 1.40B | -2.59% | 4,289,511 | - |
| 138 | ARDX | Ardelyx, Inc. | 1.40B | -0.35% | 3,375,545 | 427.68M |
| 139 | MLTX | MoonLake Immunotherapeutics | 1.40B | -1.09% | 811,291 | - |
| 140 | GHRS | GH Research PLC | 1.37B | -1.91% | 133,479 | - |
| 141 | INBX | Inhibrx Biosciences, Inc. | 1.37B | -0.43% | 331,248 | 1.30M |
| 142 | SVRA | Savara Inc. | 1.34B | -0.56% | 997,667 | - |
| 143 | MAZE | Maze Therapeutics, Inc. | 1.32B | -1.69% | 533,783 | 20.00M |
| 144 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.29B | 1.01% | 1,455,979 | 204.73M |
| 145 | DMRA | Damora Therapeutics, Inc. | 1.27B | 2.59% | 397,099 | - |
| 146 | AKTS | Aktis Oncology, Inc. | 1.25B | 9.38% | 548,406 | 8.28M |
| 147 | IMTX | Immatics N.V. | 1.24B | -3.61% | 208,616 | 43.00M |
| 148 | MPLT | MapLight Therapeutics, Inc. | 1.23B | -2.86% | 203,084 | - |
| 149 | MNKD | MannKind Corporation | 1.20B | -3.25% | 3,164,062 | 360.78M |
| 150 | AVLN | Avalyn Pharma Inc. | 1.17B | -2.37% | 383,857 | - |
| 151 | ZBIO | Zenas BioPharma, Inc. | 1.15B | -2.78% | 392,326 | 10.00M |
| 152 | COAG | Hemab Therapeutics Holdings, Inc. | 1.13B | 1.71% | 375,446 | - |
| 153 | WVE | Wave Life Sciences Ltd. | 1.10B | -4.33% | 2,325,984 | 71.80M |
| 154 | ABSI | Absci Corporation | 1.09B | -3.71% | 3,835,562 | 1.84M |
| 155 | EYPT | EyePoint, Inc. | 1.08B | 6.62% | 1,471,638 | 7.61M |
| 156 | DBVT | DBV Technologies S.A. | 1.01B | -7.56% | 160,832 | 5.74M |
| 157 | CRVS | Corvus Pharmaceuticals, Inc. | 987.22M | -1.34% | 1,181,417 | - |
| 158 | SPRY | ARS Pharmaceuticals, Inc. | 963.24M | -1.12% | 874,818 | 98.99M |
| 159 | SPTX | Seaport Therapeutics, Inc. | 961.94M | 3.04% | 199,066 | - |
| 160 | JBIO | Jade Biosciences, Inc. | 921.86M | -3.54% | 1,324,333 | - |
| 161 | XNCR | Xencor, Inc. | 904.53M | -0.08% | 871,478 | 97.36M |
| 162 | MGTX | MeiraGTx Holdings plc | 899.24M | -0.41% | 499,948 | 79.76M |
| 163 | PHAR | Pharming Group N.V. | 896.95M | -2.42% | 2,017 | 369.49M |
| 164 | ABUS | Arbutus Biopharma Corporation | 867.19M | 1.62% | 1,104,230 | 191.45M |
| 165 | LXRX | Lexicon Pharmaceuticals, Inc. | 866.18M | -0.51% | 1,853,928 | 69.64M |
| 166 | TBPH | Theravance Biopharma, Inc. | 860.42M | 2.27% | 340,544 | 109.78M |
| 167 | ORIC | ORIC Pharmaceuticals, Inc. | 860.23M | -1.07% | 1,151,039 | - |
| 168 | SANA | Sana Biotechnology, Inc. | 848.72M | -0.70% | 2,006,796 | - |
| 169 | DRTS | Alpha Tau Medical Ltd. | 843.15M | -3.31% | 370,039 | - |
| 170 | ODTX | Odyssey Therapeutics, Inc. | 843.00M | 1.25% | 451,893 | 2.98M |
| 171 | JANX | Janux Therapeutics, Inc. | 835.49M | -0.29% | 617,138 | 13.73M |
| 172 | KURA | Kura Oncology, Inc. | 834.48M | -1.47% | 1,014,441 | 71.64M |
| 173 | CGEM | Cullinan Therapeutics, Inc. | 832.76M | -0.44% | 1,062,329 | - |
| 174 | PHAT | Phathom Pharmaceuticals, Inc. | 828.46M | -2.61% | 749,674 | 204.89M |
| 175 | OLMA | Olema Pharmaceuticals, Inc. | 802.72M | -6.98% | 1,207,386 | - |
| 176 | LBRX | LB Pharmaceuticals Inc | 793.20M | -2.95% | 160,318 | - |
| 177 | VOR | Vor Biopharma Inc. | 764.56M | 0.28% | 749,978 | - |
| 178 | GERN | Geron Corporation | 756.99M | 2.61% | 10,258,721 | 196.12M |
| 179 | IVA | Inventiva S.A. | 755.58M | -4.79% | 474,832 | 7.94M |
| 180 | AVTX | Avalo Therapeutics, Inc. | 753.26M | -1.85% | 1,543,473 | 59.00K |
| 181 | ZVRA | Zevra Therapeutics, Inc. | 747.81M | 0.80% | 1,259,024 | 122.29M |
| 182 | ANNX | Annexon, Inc. | 740.57M | -2.59% | 2,409,029 | - |
| 183 | ANRO | Alto Neuroscience, Inc. | 736.97M | -0.80% | 267,345 | - |
| 184 | REPL | Replimune Group, Inc. | 724.99M | -2.01% | 1,550,925 | - |
| 185 | EVMN | Evommune, Inc. | 722.17M | -3.79% | 344,584 | 10.00M |
| 186 | SLDB | Solid Biosciences Inc. | 696.04M | -3.94% | 1,288,441 | - |
| 187 | AURA | Aura Biosciences, Inc. | 692.68M | -2.64% | 496,683 | - |
| 188 | OCS | Oculis Holding AG | 691.44M | -1.38% | 615,722 | 1.40M |
| 189 | RLMD | Relmada Therapeutics, Inc. | 687.03M | 2.83% | 2,024,173 | - |
| 190 | OMER | Omeros Corporation | 686.12M | 1.61% | 2,608,248 | 9.89M |
| 191 | CRMD | CorMedix Inc. | 679.39M | 0.81% | 847,802 | 400.05M |
| 192 | DSGN | Design Therapeutics, Inc. | 669.54M | -3.77% | 626,120 | - |
| 193 | TENX | Tenax Therapeutics, Inc. | 667.09M | -1.90% | 795,067 | - |
| 194 | ALLO | Allogene Therapeutics, Inc. | 655.79M | -2.06% | 5,045,928 | 22.00K |
| 195 | CTMX | CytomX Therapeutics, Inc. | 637.87M | -3.62% | 10,574,125 | 35.54M |
| 196 | IMMX | Immix Biopharma, Inc. | 622.20M | 3.19% | 2,618,801 | - |
| 197 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 619.23M | - | 551,143 | - |
| 198 | CLYM | Climb Bio, Inc. | 613.26M | -6.79% | 864,670 | - |
| 199 | ACRS | Aclaris Therapeutics, Inc. | 606.14M | -0.46% | 1,086,083 | 8.37M |
| 200 | RIGL | Rigel Pharmaceuticals, Inc. | 600.58M | -2.87% | 388,622 | 299.77M |
| 201 | TRAX | First Tracks Biotherapeutics, Inc. | 598.06M | -4.14% | 547,651 | - |
| 202 | CBIO | Crescent Biopharma, Inc. | 596.46M | -1.32% | 124,156 | 11.88M |
| 203 | SGP | SpyGlass Pharma, Inc. | 586.97M | -7.29% | 103,710 | - |
| 204 | DRUG | Bright Minds Biosciences Inc. | 584.97M | 1.10% | 223,545 | - |
| 205 | CADL | Candel Therapeutics, Inc. | 583.96M | -6.89% | 1,913,082 | - |
| 206 | ACHV | Achieve Life Sciences, Inc. | 569.76M | -0.89% | 1,785,854 | - |
| 207 | TECX | Tectonic Therapeutic, Inc. | 566.26M | 2.11% | 88,228 | - |
| 208 | MDXG | MiMedx Group, Inc. | 551.10M | 0.54% | 1,310,065 | 389.42M |
| 209 | DNA | Ginkgo Bioworks Holdings, Inc. | 536.31M | -0.24% | 734,575 | 151.40M |
| 210 | GYRE | Gyre Therapeutics, Inc. | 531.78M | -0.68% | 75,447 | 117.05M |
| 211 | XOMA | XOMA Royalty Corporation | 523.96M | -0.41% | 133,638 | 48.56M |
| 212 | PRME | Prime Medicine, Inc. | 518.37M | -1.03% | 2,151,235 | 4.03M |
| 213 | PROK | ProKidney Corp. | 510.48M | 1.20% | 484,631 | 889.00K |
| 214 | ALT | Altimmune, Inc. | 509.52M | -0.76% | 2,907,176 | 36.00K |
| 215 | VALN | Valneva SE | 501.51M | -0.56% | 17,880 | 180.25M |
| 216 | AGMB | AgomAb Therapeutics NV | 492.48M | - | 102,684 | - |
| 217 | EIKN | Eikon Therapeutics, Inc. | 491.04M | -2.79% | 189,999 | - |
| 218 | KYTX | Kyverna Therapeutics, Inc. | 479.40M | -2.82% | 598,399 | - |
| 219 | ARVN | Arvinas, Inc. | 478.75M | -0.93% | 519,472 | 89.40M |
| 220 | RZLT | Rezolute, Inc. | 477.41M | 5.54% | 2,089,110 | - |
| 221 | STRO | Sutro Biopharma, Inc. | 466.79M | -6.72% | 344,088 | 99.61M |
| 222 | NGNE | Neurogene Inc. | 463.79M | -1.71% | 160,708 | 925.00K |
| 223 | CTNM | Contineum Therapeutics, Inc. | 463.59M | -2.52% | 590,903 | - |
| 224 | ASMB | Assembly Biosciences, Inc. | 462.34M | -0.04% | 116,939 | 71.10M |
| 225 | CABA | Cabaletta Bio, Inc. | 456.55M | -6.98% | 6,157,109 | - |
| 226 | FDMT | 4D Molecular Therapeutics, Inc. | 453.24M | -5.97% | 766,910 | 88.24M |
| 227 | OVID | Ovid Therapeutics Inc. | 440.47M | 4.42% | 2,363,567 | 7.12M |
| 228 | PRTA | Prothena Corporation plc | 434.01M | 1.72% | 586,273 | 57.94M |
| 229 | ARTV | Artiva Biotherapeutics, Inc. | 432.92M | -2.94% | 796,312 | 251.00K |
| 230 | CCCC | C4 Therapeutics, Inc. | 424.58M | 0.52% | 1,542,797 | 34.86M |
| 231 | INDP | Indaptus Therapeutics, Inc. | 421.26M | 0.81% | 256,787 | - |
| 232 | FBRX | Forte Biosciences, Inc. | 419.07M | -4.99% | 186,336 | - |
| 233 | MNPR | Monopar Therapeutics Inc. | 417.67M | 1.43% | 78,395 | - |
| 234 | PRLD | Prelude Therapeutics Incorporated | 416.55M | -5.83% | 450,507 | 16.72M |
| 235 | ANL | Adlai Nortye Ltd. | 402.00M | -11.30% | 155,167 | 5.00M |
| 236 | VTVT | vTv Therapeutics Inc. | 400.08M | -3.88% | 78,498 | 36.84M |
| 237 | OCGN | Ocugen, Inc. | 399.46M | -3.28% | 7,714,206 | 4.47M |
| 238 | AUTL | Autolus Therapeutics plc | 396.55M | -0.67% | 877,299 | 92.62M |
| 239 | EPRX | Eupraxia Pharmaceuticals Inc. | 393.20M | -3.05% | 594,624 | - |
| 240 | IPSC | Century Therapeutics, Inc. | 393.17M | -5.22% | 785,981 | 109.16M |
| 241 | SGMT | Sagimet Biosciences Inc. | 389.04M | -2.63% | 1,246,761 | - |
| 242 | BNTC | Benitec Biopharma Inc. | 381.33M | -2.03% | 86,868 | - |
| 243 | XFOR | X4 Pharmaceuticals, Inc. | 381.05M | -0.98% | 461,102 | 9.01M |
| 244 | LXEO | Lexeo Therapeutics, Inc. | 372.98M | 2.15% | 724,366 | - |
| 245 | PBYI | Puma Biotechnology, Inc. | 364.95M | 1.41% | 216,671 | 227.18M |
| 246 | EDIT | Editas Medicine, Inc. | 362.17M | -4.07% | 2,258,719 | 38.69M |
| 247 | RGNX | REGENXBIO Inc. | 358.26M | -1.98% | 967,544 | 87.82M |
| 248 | LRMR | Larimar Therapeutics, Inc. | 354.90M | -5.29% | 926,176 | - |
| 249 | CMPX | Compass Therapeutics, Inc. | 354.77M | -3.43% | 2,532,656 | 850.00K |
| 250 | VSTM | Verastem, Inc. | 352.37M | 0.25% | 1,512,590 | 49.59M |
| 251 | ENTA | Enanta Pharmaceuticals, Inc. | 350.98M | 5.51% | 142,652 | 69.21M |
| 252 | GLSI | Greenwich LifeSciences, Inc. | 350.52M | 2.01% | 132,852 | - |
| 253 | VNDA | Vanda Pharmaceuticals Inc. | 344.58M | -2.55% | 944,891 | 217.78M |
| 254 | AVIR | Atea Pharmaceuticals, Inc. | 340.92M | -2.07% | 287,711 | - |
| 255 | ZURA | Zura Bio Limited | 333.92M | -4.48% | 603,861 | - |
| 256 | STTK | Shattuck Labs, Inc. | 332.03M | -6.48% | 642,310 | 1.00M |
| 257 | UPB | Upstream Bio, Inc. | 322.17M | -2.95% | 519,893 | 3.32M |
| 258 | ABEO | Abeona Therapeutics Inc. | 322.02M | -0.35% | 1,564,070 | 14.54M |
| 259 | IRD | Opus Genetics, Inc. | 317.44M | -0.38% | 766,758 | 11.98M |
| 260 | SLN | Silence Therapeutics plc | 316.94M | -4.14% | 216,836 | 839.00K |
| 261 | NVCT | Nuvectis Pharma, Inc. | 316.71M | 7.09% | 215,355 | - |
| 262 | CNXU | Conexeu Sciences Inc. | 316.38M | 27.49% | 123,584 | - |
| 263 | FENC | Fennec Pharmaceuticals Inc. | 311.24M | -2.50% | 248,570 | 51.00M |
| 264 | DMAC | DiaMedica Therapeutics Inc. | 306.60M | 1.07% | 187,982 | - |
| 265 | RCKT | Rocket Pharmaceuticals, Inc. | 305.74M | -2.10% | 2,171,825 | - |
| 266 | LCTX | Lineage Cell Therapeutics, Inc. | 299.16M | -2.44% | 1,649,594 | 14.78M |
| 267 | PALI | Palisade Bio, Inc. | 298.02M | 5.33% | 3,491,900 | - |
| 268 | OABI | OmniAb, Inc. | 292.84M | -4.27% | 691,649 | 28.94M |
| 269 | LYEL | Lyell Immunopharma, Inc. | 290.28M | -8.19% | 198,605 | 31.00K |
| 270 | NMRA | Neumora Therapeutics, Inc. | 289.04M | 70.59% | 28,535,159 | - |
| 271 | IKT | Inhibikase Therapeutics, Inc. | 284.61M | - | 694,517 | 1.00 |
| 272 | BCYC | Bicycle Therapeutics plc | 280.64M | -3.13% | 947,789 | 63.50M |
| 273 | NAUT | Nautilus Biotechnology, Inc. | 275.76M | -3.56% | 393,948 | - |
| 274 | NAGE | Niagen Bioscience, Inc. | 273.75M | -2.56% | 571,588 | 130.42M |
| 275 | ELDN | Eledon Pharmaceuticals, Inc. | 269.01M | 1.46% | 574,423 | - |
| 276 | RNAC | Cartesian Therapeutics, Inc. | 265.90M | 5.23% | 368,197 | 1.78M |
| 277 | IMRX | Immuneering Corporation | 265.26M | -2.15% | 1,135,237 | - |
| 278 | SRZN | Surrozen, Inc. | 264.14M | -1.69% | 104,768 | 7.49M |
| 279 | IVVD | Invivyd, Inc. | 262.73M | 2.67% | 5,002,740 | 55.87M |
| 280 | SABS | SAB Biotherapeutics, Inc. | 257.21M | -6.15% | 1,921,546 | 114.70K |
| 281 | ZNTL | Zentalis Pharmaceuticals, Inc. | 250.58M | -6.88% | 1,051,720 | 26.87M |
| 282 | ARMP | Armata Pharmaceuticals, Inc. | 249.16M | -1.74% | 152,440 | 5.20M |
| 283 | MGNX | MacroGenics, Inc. | 246.62M | -6.05% | 548,417 | 157.08M |
| 284 | VRXA | VERAXA Biotech AG | 238.56M | -55.50% | 562,938 | - |
| 285 | SLGL | Sol-Gel Technologies Ltd. | 238.21M | -1.29% | 50,880 | 18.47M |
| 286 | IFRX | InflaRx N.V. | 235.67M | -1.23% | 1,042,897 | 33.82K |
| 287 | FHTX | Foghorn Therapeutics Inc. | 235.44M | -2.43% | 87,723 | 28.22M |
| 288 | ACIU | AC Immune SA | 235.11M | 1.28% | 124,115 | 4.62M |
| 289 | TRDA | Entrada Therapeutics, Inc. | 234.22M | -1.22% | 173,987 | 5.74M |
| 290 | AVXL | Anavex Life Sciences Corp. | 233.53M | 0.80% | 951,277 | - |
| 291 | ADAG | Adagene Inc. | 231.91M | -3.57% | 60,597 | 7.67M |
| 292 | FULC | Fulcrum Therapeutics, Inc. | 230.55M | -1.42% | 6,026,556 | 80.00M |
| 293 | OBIO | Orchestra BioMed Holdings, Inc. | 230.54M | -3.02% | 479,402 | 32.72M |
| 294 | CNTN | Canton Strategic Holdings, Inc. | 230.36M | 2.80% | 2,286,711 | - |
| 295 | HUMA | Humacyte, Inc. | 228.68M | -3.74% | 7,073,998 | 2.02M |
| 296 | CLLS | Cellectis S.A. | 226.62M | -1.93% | 9,472 | 75.11M |
| 297 | CDXS | Codexis, Inc. | 225.42M | -0.40% | 349,516 | 78.09M |
| 298 | FATE | Fate Therapeutics, Inc. | 221.46M | -5.47% | 1,862,501 | 6.32M |
| 299 | QTTB | Q32 Bio Inc. | 216.19M | -0.86% | 427,794 | 53.74M |
| 300 | RNA | Atrium Therapeutics, Inc. | 215.70M | -1.10% | 160,536 | 36.68M |
| 301 | HELP | Cybin Inc. | 214.65M | 0.94% | 516,566 | - |
| 302 | CAMP | Camp4 Therapeutics Corporation | 214.45M | 4.29% | 867,459 | 3.93M |
| 303 | TARA | Protara Therapeutics, Inc. | 214.14M | -3.30% | 510,740 | - |
| 304 | VYGR | Voyager Therapeutics, Inc. | 213.29M | -2.75% | 362,770 | 36.49M |
| 305 | CHRS | Coherus Oncology, Inc. | 212.86M | 1.47% | 1,116,592 | 46.88M |
| 306 | NGEN | NervGen Pharma Corp. | 212.41M | 7.53% | 796,998 | - |
| 307 | KPTI | Karyopharm Therapeutics Inc. | 206.23M | -5.60% | 322,103 | 151.12M |
| 308 | WHWK | Whitehawk Therapeutics, Inc. | 206.22M | 1.71% | 345,873 | 7.15M |
| 309 | LENZ | LENZ Therapeutics, Inc. | 204.43M | -1.66% | 239,654 | 20.99M |
| 310 | NERV | Minerva Neurosciences, Inc. | 203.59M | -0.46% | 96,405 | - |
| 311 | ARCT | Arcturus Therapeutics Holdings Inc. | 202.94M | -2.59% | 200,415 | 54.71M |
| 312 | KROS | Keros Therapeutics, Inc. | 198.51M | -2.05% | 264,454 | 33.18M |
| 313 | CGEN | Compugen Ltd. | 192.01M | 0.50% | 346,043 | 72.66M |
| 314 | UNCY | Unicycive Therapeutics, Inc. | 191.44M | 0.70% | 1,109,501 | - |
| 315 | OTLK | Outlook Therapeutics, Inc. | 189.76M | 35.34% | 42,831,637 | 333.14K |
| 316 | NKTX | Nkarta, Inc. | 187.45M | -4.38% | 343,318 | - |
| 317 | YDES | YD Bio Limited | 187.05M | -21.53% | 271,453 | 510.36K |
| 318 | IMUX | Immunic, Inc. | 186.75M | -2.14% | 118,851 | - |
| 319 | ALXO | ALX Oncology Holdings Inc. | 185.70M | -12.66% | 2,946,927 | - |
| 320 | TNXP | Tonix Pharmaceuticals Holding Corp. | 185.39M | 0.95% | 372,222 | 17.56M |
| 321 | TTRX | Turn Therapeutics Inc. | 183.49M | -4.05% | 31,630 | - |
| 322 | MDWD | MediWound Ltd. | 178.26M | -0.57% | 63,945 | 14.48M |
| 323 | MIST | Milestone Pharmaceuticals Inc. | 175.50M | -1.53% | 1,126,482 | 1.78M |
| 324 | NBP | NovaBridge Biosciences | 174.63M | 2.72% | 684,805 | - |
| 325 | EQ | Equillium, Inc. | 173.87M | -1.79% | 256,387 | 4.39M |
| 326 | GALT | Galectin Therapeutics Inc. | 173.86M | 0.76% | 383,014 | - |
| 327 | OKUR | OnKure Therapeutics, Inc. | 171.68M | 1.19% | 259,067 | - |
| 328 | ANTX | AN2 Therapeutics, Inc. | 171.34M | -3.05% | 365,978 | - |
| 329 | ALEC | Alector, Inc. | 170.98M | 4.05% | 712,030 | 18.42M |
| 330 | IPHA | Innate Pharma S.A. | 168.76M | - | 18,042 | 10.57M |
| 331 | CRBU | Caribou Biosciences, Inc. | 167.62M | 1.81% | 2,087,763 | 11.20M |
| 332 | PLX | Protalix BioTherapeutics, Inc. | 165.98M | - | 228,416 | 76.38M |
| 333 | ABOS | Acumen Pharmaceuticals, Inc. | 165.40M | -2.14% | 413,581 | - |
| 334 | DTIL | Precision BioSciences, Inc. | 162.81M | 1.61% | 209,191 | 45.07M |
| 335 | SPRO | Spero Therapeutics, Inc. | 160.39M | -4.81% | 1,432,160 | 61.19M |
| 336 | PRQR | ProQR Therapeutics N.V. | 160.15M | -2.56% | 204,331 | 15.73M |
| 337 | KZIA | Kazia Therapeutics Limited | 157.35M | -2.20% | 178,863 | 1.27M |
| 338 | ORMP | Oramed Pharmaceuticals Inc. | 154.29M | -1.82% | 122,333 | 2.00M |
| 339 | KRRO | Korro Bio, Inc. | 153.74M | -8.58% | 221,498 | 3.84M |
| 340 | ENLV | Enlivex Ltd. | 151.91M | -4.53% | 310,485 | - |
| 341 | MOLN | Molecular Partners AG | 148.90M | 1.82% | 24,540 | 856.30K |
| 342 | TNYA | Tenaya Therapeutics, Inc. | 147.56M | -5.38% | 3,476,501 | 225.00K |
| 343 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 146.00M | -5.29% | 482,853 | - |
| 344 | NRXP | NRx Pharmaceuticals, Inc. | 143.70M | -2.70% | 549,212 | 2.29M |
| 345 | TLSA | Tiziana Life Sciences Ltd | 142.24M | -0.90% | 112,274 | - |
| 346 | HURA | TuHURA Biosciences, Inc. | 142.01M | -1.76% | 323,605 | - |
| 347 | GNLX | Genelux Corporation | 134.56M | 0.33% | 158,496 | 8.00K |
| 348 | NTHI | NeOnc Technologies Holdings, Inc. | 131.14M | 14.86% | 223,154 | 39.99K |
| 349 | ACOG | Alpha Cognition Inc. | 130.86M | 0.33% | 24,964 | 10.83M |
| 350 | SPRB | Spruce Biosciences, Inc. | 129.63M | -5.63% | 61,587 | 697.00K |
| 351 | ADCT | ADC Therapeutics SA | 126.72M | -5.11% | 1,284,089 | 79.18M |
| 352 | ALPS | Alps Group Inc | 125.57M | -1.99% | 19,481 | 3.74M |
| 353 | CNTB | Connect Biopharma Holdings Limited | 125.30M | -3.40% | 256,079 | 233.00K |
| 354 | AGEN | Agenus Inc. | 124.09M | -8.31% | 836,459 | 123.87M |
| 355 | GUTS | Fractyl Health, Inc. | 123.11M | -8.71% | 6,907,463 | 3.00K |
| 356 | MENS | Jyong Biotech Ltd. | 118.77M | - | 189,925 | - |
| 357 | ENGN | enGene Therapeutics Inc. | 117.23M | -1.13% | 1,216,351 | - |
| 358 | ONCY | Oncolytics Biotech Inc. | 113.33M | 11.68% | 2,637,368 | - |
| 359 | COYA | Coya Therapeutics, Inc. | 113.06M | -1.43% | 154,032 | 7.94M |
| 360 | CGTX | Cognition Therapeutics, Inc. | 112.59M | 4.13% | 1,078,558 | - |
| 361 | PYXS | Pyxis Oncology, Inc. | 110.87M | 0.57% | 399,226 | 13.86M |
| 362 | PEPG | PepGen Inc. | 109.98M | 3.92% | 1,171,815 | - |
| 363 | PLYX | Polaryx Therapeutics, Inc. | 108.42M | -2.14% | 65,859 | - |
| 364 | ALDX | Aldeyra Therapeutics, Inc. | 107.37M | 1.14% | 926,923 | - |
| 365 | KLRS | Kalaris Therapeutics, Inc. | 103.97M | 2.34% | 45,120 | - |
| 366 | VRCA | Verrica Pharmaceuticals Inc. | 103.07M | 3.27% | 43,202 | 37.16M |
| 367 | VANI | Vivani Medical, Inc. | 100.90M | 3.54% | 344,023 | - |
| 368 | CBUS | Cibus, Inc. | 99.99M | 3.15% | 115,018 | 3.64M |
| 369 | PTHS | Pelthos Therapeutics Inc. | 97.39M | 5.74% | 20,954 | 27.70M |
| 370 | FBIO | Fortress Biotech, Inc. | 97.33M | 2.45% | 375,026 | 66.16M |
| 371 | BDTX | Black Diamond Therapeutics, Inc. | 96.27M | -2.33% | 1,867,390 | 70.00M |
| 372 | CSBR | Champions Oncology, Inc. | 95.54M | 8.52% | 16,821 | 57.95M |
| 373 | SEER | Seer, Inc. | 94.02M | - | 141,497 | 15.17M |
| 374 | PMN | ProMIS Neurosciences, Inc. | 91.11M | 1.09% | 17,036 | - |
| 375 | INO | Inovio Pharmaceuticals, Inc. | 90.95M | 0.91% | 1,357,585 | 65.34K |
| 376 | PYPD | PolyPid Ltd. | 89.35M | -0.11% | 58,209 | - |
| 377 | ANIX | Anixa Biosciences, Inc. | 88.80M | 5.24% | 238,203 | - |
| 378 | RNTX | Rein Therapeutics Inc. | 87.92M | 0.27% | 1,261,814 | - |
| 379 | ATRA | Atara Biotherapeutics, Inc. | 86.68M | -3.41% | 126,095 | 23.14M |
| 380 | CRDF | Cardiff Oncology, Inc. | 86.15M | -11.27% | 1,725,848 | 525.00K |
| 381 | ICCC | ImmuCell Corporation | 84.86M | -1.57% | 14,093 | 29.93M |
| 382 | RLYB | Rallybio Corporation | 84.11M | - | 20,102 | 858.00K |
| 383 | BMEA | Biomea Fusion, Inc. | 83.87M | -3.33% | 805,368 | - |
| 384 | NRXS | NeurAxis, Inc. | 83.10M | -1.32% | 69,070 | 4.28M |
| 385 | ATHE | Alterity Therapeutics Limited | 81.54M | 5.44% | 39,654 | 4.43M |
| 386 | ACET | Adicet Bio, Inc. | 81.49M | -4.32% | 77,747 | - |
| 387 | AARD | Aardvark Therapeutics, Inc. | 81.16M | -3.12% | 107,636 | - |
| 388 | MAIA | MAIA Biotechnology, Inc. | 80.26M | -2.94% | 358,140 | - |
| 389 | LIXT | Lixte Biotechnology Holdings, Inc. | 79.93M | 2.38% | 774,819 | - |
| 390 | OSTX | OS Therapies Incorporated | 78.83M | 2.91% | 1,090,909 | - |
| 391 | OKYO | OKYO Pharma Limited | 78.72M | -1.32% | 47,459 | - |
| 392 | CUE | Cue Biopharma, Inc. | 77.77M | -7.40% | 63,387 | 32.73M |
| 393 | GANX | Gain Therapeutics, Inc. | 76.35M | 2.29% | 601,119 | - |
| 394 | ANVS | Annovis Bio, Inc. | 76.15M | 0.56% | 670,958 | - |
| 395 | RANI | Rani Therapeutics Holdings, Inc. | 75.83M | -1.09% | 750,574 | 3.17M |
| 396 | LONA | LeonaBio, Inc. | 74.02M | -6.75% | 25,408 | - |
| 397 | PLRX | Pliant Therapeutics, Inc. | 73.69M | 4.39% | 513,357 | - |
| 398 | HYFT | MindWalk Holdings Corp. | 73.01M | -5.77% | 320,235 | 20.70M |
| 399 | HRTX | Heron Therapeutics, Inc. | 72.30M | -5.47% | 2,824,005 | 150.71M |
| 400 | XBIT | XBiotech Inc. | 71.65M | - | 8,350 | - |
| 401 | BYSI | BeyondSpring Inc. | 65.79M | -3.03% | 5,196 | 1.88M |
| 402 | MNOV | MediciNova, Inc. | 64.48M | 4.80% | 124,047 | 596.64K |
| 403 | ACRV | Acrivon Therapeutics, Inc. | 63.77M | -1.97% | 318,372 | - |
| 404 | CING | Cingulate Inc. | 62.93M | -3.85% | 632,395 | - |
| 405 | EXOZ | eXoZymes, Inc. | 62.91M | 0.95% | 2,530 | -700.00 |
| 406 | IMA | ImageneBio, Inc. | 61.47M | -1.62% | 15,148 | 800.00K |
| 407 | CNTX | Context Therapeutics Inc. | 59.75M | -4.24% | 6,096,460 | - |
| 408 | FLNA | Filana Therapeutics, Inc. | 58.94M | 0.83% | 442,284 | - |
| 409 | IBO | Impact BioMedical Inc. | 58.84M | -1.14% | 21,833 | 39.00K |
| 410 | INKT | MiNK Therapeutics, Inc. | 58.84M | -5.82% | 23,059 | - |
| 411 | KALA | KALA BIO, Inc. | 58.37M | 18.94% | 175,192 | - |
| 412 | ENTX | Entera Bio Ltd. | 58.09M | -2.48% | 88,035 | 42.00K |
| 413 | MCRB | Seres Therapeutics, Inc. | 57.81M | 6.23% | 80,919 | 1.15M |
| 414 | PMVP | PMV Pharmaceuticals, Inc. | 57.60M | 1.89% | 120,535 | - |
| 415 | IBIO | iBio, Inc. | 56.02M | -6.06% | 1,049,311 | 300.00K |
| 416 | EDSA | Edesa Biotech, Inc. | 55.71M | 5.56% | 194,682 | - |
| 417 | TCRX | TScan Therapeutics, Inc. | 55.42M | -10.76% | 812,273 | 9.14M |
| 418 | PDSB | PDS Biotechnology Corporation | 53.58M | -5.88% | 1,359,250 | - |
| 419 | TIL | Instil Bio, Inc. | 51.61M | -3.91% | 71,289 | - |
| 420 | ELOX | Eloxx Pharmaceuticals, Inc. | 51.46M | -13.26% | 22,587 | - |
| 421 | ELTX | Elicio Therapeutics, Inc. | 50.77M | -32.35% | 4,871,359 | - |
| 422 | VERU | Veru Inc. | 50.24M | - | 688,664 | 16.89M |
| 423 | RADX | Radiopharm Theranostics Limited | 50.14M | -0.90% | 32,530 | 10.86M |
| 424 | DWTX | Dogwood Therapeutics, Inc. | 50.10M | -4.46% | 26,638 | - |
| 425 | LTRN | Lantern Pharma Inc. | 49.89M | 5.96% | 214,348 | - |
| 426 | XLO | Xilio Therapeutics, Inc. | 49.36M | -1.08% | 17,456 | 53.48M |
| 427 | ACTU | Actuate Therapeutics, Inc. | 48.57M | -0.98% | 52,922 | - |
| 428 | IMMP | Immutep Limited | 47.95M | -3.81% | 235,496 | 5.28M |
| 429 | MREO | Mereo BioPharma Group plc | 46.61M | -1.35% | 1,227,814 | 500.00K |
| 430 | HYPD | Hyperion DeFi, Inc. | 46.03M | 10.96% | 1,293,752 | 1.04M |
| 431 | GNTA | Genenta Science S.p.A. | 44.12M | 3.89% | 357,211 | - |
| 432 | TELO | Telomir Pharmaceuticals, Inc. | 44.01M | -0.78% | 130,610 | - |
| 433 | ATYR | aTyr Pharma, Inc. | 43.91M | 1.02% | 643,231 | 190.00K |
| 434 | ESLA | Estrella Immunopharma, Inc. | 43.03M | -2.91% | 39,581 | - |
| 435 | MGX | Metagenomi Therapeutics, Inc. | 42.92M | -2.56% | 239,839 | 22.33M |
| 436 | CRVO | CervoMed Inc. | 41.85M | 82.26% | 200,678,221 | 2.09M |
| 437 | NTRB | Nutriband Inc. | 40.24M | -2.93% | 17,017 | 1.80M |
| 438 | RNXT | RenovoRx, Inc. | 39.67M | -0.70% | 83,894 | 1.49M |
| 439 | GOSS | Gossamer Bio, Inc. | 39.36M | 0.42% | 8,744,485 | 55.54M |
| 440 | TVGN | Tevogen Bio Holdings Inc. | 38.32M | -8.68% | 12,726 | - |
| 441 | GRCE | Grace Therapeutics, Inc. | 34.35M | 0.45% | 210,055 | - |
| 442 | INMB | INmune Bio Inc. | 34.03M | - | 161,620 | 50.00K |
| 443 | GRDX | GridAI Technologies Corp. | 33.86M | 4.73% | 76,754 | - |
| 444 | ABVC | ABVC BioPharma, Inc. | 32.60M | 2.38% | 431,238 | 797.92K |
| 445 | APLM | Apollomics, Inc. | 31.82M | 4.63% | 6,241 | 8.84M |
| 446 | LSTA | Lisata Therapeutics, Inc. | 31.78M | 1.16% | 13,841 | 170.00K |
| 447 | BOLD | Boundless Bio, Inc. | 31.67M | 0.71% | 141,117 | - |
| 448 | DARE | Daré Bioscience, Inc. | 31.61M | 6.57% | 365,395 | 1.16M |
| 449 | PSTV | Plus Therapeutics, Inc. | 31.46M | -5.77% | 240,228 | 5.18M |
| 450 | LITS | Lite Strategy, Inc. | 31.30M | 14.93% | 1,474,451 | - |
| 451 | NNVC | NanoViricides, Inc. | 30.98M | -3.55% | 386,993 | - |
| 452 | ALGS | Aligos Therapeutics, Inc. | 30.88M | -2.35% | 41,316 | 4.71M |
| 453 | ATNM | Actinium Pharmaceuticals, Inc. | 30.75M | -2.00% | 219,531 | 90.00K |
| 454 | SER | Serina Therapeutics, Inc. | 30.39M | 6.81% | 141,821 | 130.00K |
| 455 | SNTI | Senti Biosciences Holdings, Inc. | 28.96M | -3.85% | 121,975 | 38.00K |
| 456 | BRNS | Barinthus Biotherapeutics plc | 28.57M | -0.16% | 72,803 | 14.97M |
| 457 | EVAX | Evaxion A/S | 28.52M | -5.00% | 33,435 | 7.53M |
| 458 | DYAI | Dyadic International, Inc. | 28.39M | -2.10% | 130,719 | 3.81M |
| 459 | KYNB | Kyntra Bio, Inc. | 27.97M | 0.58% | 6,216 | 7.44M |
| 460 | IGC | IGC Pharma, Inc. | 27.43M | -1.00% | 854,391 | 1.11M |
| 461 | VTGN | Vistagen Therapeutics, Inc. | 27.34M | 20.42% | 4,394,251 | 1.27M |
| 462 | SKYE | Skye Bioscience, Inc. | 25.24M | -1.52% | 209,506 | - |
| 463 | BCTX | BriaCell Therapeutics Corp. | 24.75M | 3.28% | 102,580 | - |
| 464 | NRSN | NeuroSense Therapeutics Ltd. | 24.71M | 1.75% | 79,560 | - |
| 465 | TVRD | Tvardi Therapeutics, Inc. | 24.67M | -1.50% | 39,744 | - |
| 466 | PLUR | Pluri Inc. | 24.28M | -3.43% | 4,876 | 1.08M |
| 467 | LGVN | Longeveron Inc. | 23.98M | -2.53% | 83,886 | 1.22M |
| 468 | NEUP | Neuphoria Therapeutics Inc. | 23.13M | -0.23% | 69,603 | -13.27K |
| 469 | QNTM | Quantum BioPharma Ltd. | 22.87M | -1.62% | 95,675 | - |
| 470 | PTN | Palatin Technologies, Inc. | 22.61M | -5.04% | 15,973 | 12.88M |
| 471 | MRKR | Marker Therapeutics, Inc. | 22.51M | - | 72,305 | 3.55M |
| 472 | ALLR | Allarity Therapeutics, Inc. | 22.11M | -3.38% | 160,370 | 345.00K |
| 473 | PLRZ | Polyrizon Ltd. | 21.43M | 5.72% | 81,647 | - |
| 474 | CELU | Celularity Inc. | 21.33M | -4.31% | 50,342 | 26.55M |
| 475 | VYNE | VYNE Therapeutics Inc. | 21.09M | 1.75% | 121,758 | 454.00K |
| 476 | CLRB | Cellectar Biosciences, Inc. | 19.58M | 4.70% | 298,806 | - |
| 477 | FTH | Faeth Therapeutics, Inc. | 19.50M | 4.91% | 155,542 | - |
| 478 | ATOS | Atossa Therapeutics, Inc. | 19.12M | -5.53% | 310,191 | - |
| 479 | LPCN | Lipocine Inc. | 18.96M | 0.44% | 88,059 | 2.00M |
| 480 | TPST | Tempest Therapeutics, Inc. | 17.93M | - | 64,807 | - |
| 481 | PASG | Passage Bio, Inc. | 17.64M | - | 55,618 | - |
| 482 | AEON | AEON Biopharma, Inc. | 17.64M | 0.81% | 15,116 | - |
| 483 | HOWL | Werewolf Therapeutics, Inc. | 17.49M | -7.43% | 584,402 | 1.14M |
| 484 | NCEL | NewcelX Ltd. | 17.28M | 0.31% | 4,783 | - |
| 485 | KTTA | Pasithea Therapeutics Corp. | 17.04M | -8.93% | 728,634 | - |
| 486 | MLEC | Moolec Science SA | 16.35M | 3.01% | 7,140 | 7.83M |
| 487 | GTBP | GT Biopharma, Inc. | 16.07M | -4.91% | 1,290,081 | - |
| 488 | HIND | Vyome Holdings, Inc. | 15.44M | 1.38% | 10,619 | 152.72K |
| 489 | CRIS | Curis, Inc. | 15.19M | -8.61% | 638,990 | 7.06M |
| 490 | AKTX | Akari Therapeutics, Plc | 14.88M | -1.29% | 34,949 | - |
| 491 | CTXR | Citius Pharmaceuticals, Inc. | 14.87M | 0.31% | 203,146 | 5.61M |
| 492 | QNCX | Quince Therapeutics, Inc. | 14.68M | -3.30% | 182,294 | - |
| 493 | CVM | CEL-SCI Corporation | 14.64M | - | 480,687 | - |
| 494 | LEXX | Lexaria Bioscience Corp. | 14.60M | -2.81% | 46,878 | 368.00K |
| 495 | MBRX | Moleculin Biotech, Inc. | 14.41M | -0.37% | 137,988 | - |
| 496 | XCUR | Exicure, Inc. | 13.83M | -22.22% | 128,849 | 500.00K |
| 497 | INAB | IN8bio, Inc. | 13.59M | -0.72% | 40,495 | - |
| 498 | CALC | CalciMedica, Inc. | 13.51M | -1.38% | 143,614 | - |
| 499 | CYCN | Cyclerion Therapeutics, Inc. | 13.49M | - | 62,886 | 1.99M |
| 500 | BLRX | BioLineRx Ltd. | 13.48M | -6.01% | 11,163 | 1.40M |